HOME >> MEDICINE >> NEWS
Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control

of lung function) of 80-81 percent predicted and mean daily albuterol use (a measure of asthma control) of 0.82 puffs per day. All patients participated in the study for at least 12 weeks; and all patients (n=308) from a subset of study sites were randomized to treatment that continued for 24 weeks.

Overall, both of the treatments (Advair Diskus 100/50 BID and FP 250 mcg BID) were well tolerated. The incidence of common and pharmacologically predictable adverse events over the study period were similar for both treatments.

Advair Diskus is indicated for the long-term, twice-daily, maintenance treatment of asthma in patients 12 years of age and older. Advair is not indicated for the relief of acute bronchospasm, and does not replace fast-acting inhalers for the treatment of sudden symptoms. People switching from an oral steroid like prednisone to Advair, which contains an inhaled steroid, need to be especially careful. While adjusting to the switch, a person may not be as able to heal after surgery, infection or serious injury. Advair should be used with caution in patients with cardiovascular disorders. Some patients may experience increased blood pressure, heart rate or changes in heart rhythm. Patients should see their doctor if their asthma does not improve.


'"/>


6-Nov-2002


Page: 1 2 3

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Treatment interruption shows no benefit in drug-resistant HIV infection
9. Peanut Allergy: Major Advances in Treatment and Education
10. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
11. Treatment for behavioral disorders in children with autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... AUSTIN, Texas (PRWEB) , ... August 04, 2020 ... ... and older adults living with memory impairment, has announced the Best Memory Care ... location, access to experts, facility features and amenities. , According to the ...
(Date:8/3/2020)... FORT WORTH, Texas (PRWEB) , ... August 03, ... ... biopharmaceutical company, today announced enrollment of the first patients with first-line advanced pancreatic ... the ongoing phase 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is ...
(Date:7/22/2020)... ... ... Whatever we call them – sunspots, age spots, liver spots, or solar ... Seelal, a Certified Registered Physician Assistant specializing in Dermatology with Advanced Dermatology PC ... us look older.” , In terms of the name, ‘sunspots’ or the medical term ...
(Date:7/22/2020)... TULSA, Okla. (PRWEB) , ... July 22, 2020 ... ... today announced the launch of its new Data Curation as a Service ... targeted use case modules focus on specific clinical data curation parameters and are ...
(Date:7/18/2020)... ... ... Nader Sanai, M.D., director of the Ivy Brain Tumor Center at Barrow Neurological Institute ... (#GBMDay) on July 22, 2020 to raise national consciousness. , Glioblastoma Awareness Day ... common and aggressive form of brain cancer. It also honors those who have been ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... Psyma Group AG, ... panel and data collection provider, recently released the results of an international survey ... Germany and France. , “COVID-19 continues to have a major disruptive impact on ...
(Date:7/22/2020)... ... July 22, 2020 , ... Local animal nutrition expert, Dr. Anoosh Rakhshandeh, and ... pet food and supplies company – Pet Wants Lubbock. , Pet Wants’ specially-crafted, private-label ... vitamins and minerals for a complete and balanced diet in every bite. Pet Wants ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... company and advanced manufacturing solutions provider today announced that their CANSWAB™ nasopharyngeal swabs ... The Company has engineered a new 3D-printed swab design and has trademarked the ...
Breaking Medicine Technology:
Cached News: